Rachel Voss, MD, MPH

Cancer Focus:
Adrenal Cancer, Adrenal Nodule/Mass, GIST (Gastrointestinal Stromal Tumor), Neuroendocrine Tumor, Sarcoma, Skin Cancer (Nonmelanoma)

Cancer Focus:

Extremity Sarcoma, Retroperitoneal Sarcoma, Abdominal Sarcoma, Gastrointestinal Stromal Tumor (GIST), Adrenal Tumors, Benign Adrenal Tumors, Malignant Adrenal Tumors

Rachel K. Voss, MD, MPH – Surgical Oncology Specialist in Florida

Dr. Rachel K. Voss is a complex general surgical oncologist specializing in the surgical treatment of extremity sarcomas, complex retroperitoneal and abdominal sarcomas, gastrointestinal stromal tumors (GISTs), and benign and malignant adrenal tumors. Her practice focuses on caring for patients with complex tumors and providing individualized surgical treatment using advanced techniques.

Dr. Voss offers posterior retroperitoneoscopic adrenalectomy (PRA), a minimally invasive approach to adrenalectomy performed through the back muscles. This technique can be particularly beneficial for patients with previous abdominal surgery or for patients who require surgery on both the left and right adrenal glands. Dr. Voss is the only surgeon at Moffitt Cancer Center and one of the few surgeons in the Tampa area offering this approach.

Her clinical expertise includes surgical management of:

• Extremity sarcomas
• Complex retroperitoneal and abdominal sarcomas
• Gastrointestinal stromal tumors (GISTs)
• Benign adrenal tumors
• Malignant adrenal tumors

Dr. Voss is also dedicated to improving cancer care through health services research and patient-reported outcomes research. Her work analyzes institutional and national databases, including the National Cancer Database, to identify gaps in the delivery of surgical care across the United States. Her research has a particular focus on improving access to high-quality surgical care for patients with extremity sarcomas and GISTs.

Dr. Voss received her Doctor of Medicine from The Ohio State University College of Medicine and her Master of Public Health in Epidemiology from The University of Texas Health Sciences Center at Houston. She completed General Surgery Residency at University of California San Diego Medical Center and a Complex General Surgical Oncology Fellowship at The University of Texas MD Anderson Cancer Center.

With specialized training in complex surgical oncology and expertise in minimally invasive adrenal surgery, Dr. Voss combines advanced surgical care with research focused on improving outcomes and access to cancer treatment.

Schedule a consultation with Dr. Voss at Moffitt Cancer Center to discuss surgical treatment options for complex sarcomas, gastrointestinal stromal tumors, or adrenal tumors.

Education & Training

Fellowship:

• University of Texas MD Anderson Cancer Center - Complex General Surgical Oncology

Residency:

• University of California - General Surgery

Medical School:

• Ohio State University - MD

• Nagib N, Gabra A, Joyce D, Voss R, Becker-Weidman D, Bui M. Soft-tissue sarcoma with MN1-BEND2 fusion: second reported case and comparative analysis. J Surg Case Rep. 2026 Jun.2026(6):rjag481. Pubmedid: 42368633. Pmcid: PMC13310089.
• Monsour E, Dogra P, Giparas S, Westra WH, Voss R, Veloski C. Severe hyperandrogenism and mild autonomous cortisol secretion from a functional lipid-poor adrenal cortical adenoma. JCEM Case Rep. 2026 Apr.4(4):luag059. Pubmedid: 41971635. Pmcid: PMC13069478.
• Mathew R, Voss RK, Naghavi AO, Henderson-Jackson E, Brohl AS. Treatment and Clinical Outcome of a Patient With Spindle Cell Rhabdomyosarcoma Harboring MEIS1-FOXO1 Gene Fusion. Cureus. 2025 Jul.17(7):e89124. Pubmedid: 40896038. Pmcid: PMC12398256.
• Lippincott MD, McDonald JD, Bui MM, Gonzalez RJ, Voss RK. Non-Islet Cell Tumor Hypoglycemia Secondary to a 20 cm Intra-Abdominal Leiomyoma in a Male Patient: A Case Report and Literature Review. Case Rep Surg. 2024 Jun.2024:6651107. Pubmedid: 38911593. Pmcid: PMC11192599.
• Witt RG, Voss RK, Lewis VO, Roland CL, Keung EZ. ASO Author Reflections: Variability in Management of Sarcoma Lymph Node Metastases. Ann Surg Oncol. 2023 Jun.30(6):3677-3678. Pubmedid: 36749502.
• Witt RG, Voss RK, Chiang YJ, Nguyen S, Scally CP, Lin PP, Torres KE, Moon BS, Satcher RL, Hunt KK, Bird JE, Feig BW, Lewis VO, Roland CL, Keung EZ. ASO Visual Abstract: Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma (ETSTS): A Survey of the Society of Surgical Oncology (SSO) and Musculoskeletal Tumor Society (MSTS) Membershi. Ann Surg Oncol. 2023 Jun.30(6):3679-3680. Pubmedid: 36826618.
• Witt RG, Voss RK, Chiang YJ, Nguyen S, Scally CP, Lin PP, Torres KE, Moon BS, Satcher RL, Hunt KK, Bird JE, Feig BW, Lewis VO, Roland CL, Keung EZ. Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma: A Survey of the Society of Surgical Oncology and Musculoskeletal Tumor Society Membership. Ann Surg Oncol. 2023 Jun.30(6):3668-3676. Pubmedid: 36723723.
• Tseng WW, Swallow CJ, Strauss DC, Bonvalot S, Rutkowski P, Ford SJ, Gonzalez RJ, Gladdy RA, Gyorki DE, Fairweather M, Lee KW, Albertsmeier M, van Houdt WJ, Fau M, Nessim C, Grignani G, Cardona K, Quagliuolo V, Grignol V, Farma JM, Pennacchioli E, Fiore M, Hayes A, Tzanis D, Skoczylas J, Almond ML, Mullinax JE, Johnston W, Snow H, Haas RL, Callegaro D, Smith MJ, Bouhadiba T, Desai A, Voss R, Sanfilippo R, Jones RL, Baldini EH, Wagner AJ, Catton CN, Stacchiotti S, Thway K, Roland CL, Raut CP, Gronchi A. Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group. Ann Surg Oncol. 2022 Nov.29(12):7335-7348. Pubmedid: 35767103.
• Voss RK, Callegaro D, Chiang YJ, Fiore M, Miceli R, Keung EZ, Feig BW, Torres KE, Scally CP, Hunt KK, Gronchi A, Roland CL. ASO Visual Abstract: Sarculator is a Good Model to Predict Survival in Resected Extremity and Trunk Sarcomas in US Patients. Ann Surg Oncol. 2022 Mar. Pubmedid: 35254579.
• Voss RK, Callegaro D, Chiang YJ, Fiore M, Miceli R, Keung EZ, Feig BW, Torres KE, Scally CP, Hunt KK, Gronchi A, Roland CL. Sarculator is a Good Model to Predict Survival in Resected Extremity and Trunk Sarcomas in US Patients. Ann Surg Oncol. 2022 Feb. Pubmedid: 35224688.
• Voss RK, Massarweh NN, Chiang YJ, Somaiah N, Feig BW, Roland CL. National Utilization of Imatinib in the Management of Resected Gastrointestinal Stromal Tumors. Ann Surg Oncol. 2021 Dec.28(13):9159-9168. Pubmedid: 34046772.
• Voss RK, Massarweh NN, Roland CL. ASO Author Reflections: Imatinib Use Remains Inadequate for High-Risk GIST Patients. Ann Surg Oncol. 2021 Dec.28(13):9169-9170. Pubmedid: 34018084.
• Voss RK, Massarweh NN, Chiang YJ, Somaiah N, Feig BW, Roland CL. ASO Visual Abstract: National Utilization of Imatinib in the Management of Resected Gastrointestinal Stromal Tumors. Ann Surg Oncol. 2021 Dec.28(Suppl 3):457. Pubmedid: 34050428.
• Voss RK, Lin JC, Roper MT, Al-Temimi MH, Ruan JH, Tseng WH, Tam M, Sherman MJ, Klaristenfeld DD, Tomassi MJ. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision. Dis Colon Rectum. 2020 Apr.63(4):427-440. Pubmedid: 31996583.
• Marcus RK, Lillemoe HA, Rice DC, Mena G, Bednarski BK, Speer BB, Ramirez PT, Lasala JD, Navai N, Williams WH, Kim BJ, Voss RK, Gottumukkala VN, Aloia TA. Determining the Safety and Efficacy of Enhanced Recovery Protocols in Major Oncologic Surgery: An Institutional NSQIP Analysis. Ann Surg Oncol. 2019 Mar.26(3):782-790. Pubmedid: 30627879. Pmcid: PMC6878764.
• Voss RK, Ward EP, Ojeda-Fournier H, Blair SL. Doppler Ultrasound-Visible SignalMark Microspheres are Better Identified than HydroMARK® Clips in a Simulated Intraoperative Setting in Breast and Lung Tissue. Ann Surg Oncol. 2018 Nov.25(12):3740-3746. Pubmedid: 30178390. Pmcid: PMC6277056.
• Stucky CH, Cromwell KD, Voss RK, Chiang YJ, Woodman K, Lee JE, Cormier JN. Surgeon symptoms, strain, and selections: Systematic review and meta-analysis of surgical ergonomics. Ann Med Surg (Lond). 2018 Mar.27:1-8. Pubmedid: 29511535. Pmcid: PMC5832650.
• Keung EZ, Chiang YJ, Voss RK, Cormier JN, Torres KE, Hunt KK, Feig BW, Roland CL. Defining the incidence and clinical significance of lymph node metastasis in soft tissue sarcoma. Eur J Surg Oncol. 2018 Jan.44(1):170-177. Pubmedid: 29208319. Pmcid: PMC5747371.
• Voss RK, Grubbs EG. Response to Letter: "Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness". J Clin Endocrinol Metab. 2017 Sep.102(9):3559. Pubmedid: 28911160.
• Voss RK, Chiang YJ, Torres KE, Guadagnolo BA, Mann GN, Feig BW, Cormier JN, Roland CL. Adherence to National Comprehensive Cancer Network Guidelines is Associated with Improved Survival for Patients with Stage 2A and Stages 2B and 3 Extremity and Superficial Trunk Soft Tissue Sarcoma. Ann Surg Oncol. 2017 Oct.24(11):3271-3278. Pubmedid: 28741122. Pmcid: PMC5693748.
• Voss RK, Chiang YJ, Cromwell KD, Urbauer DL, Lee JE, Cormier JN, Stucky CH. Do No Harm, Except to Ourselves? A Survey of Symptoms and Injuries in Oncologic Surgeons and Pilot Study of an Intraoperative Ergonomic Intervention. J Am Coll Surg. 2017 Jan.224(1):16-25.e1. Pubmedid: 27693681.
• Voss RK, Feng L, Lee JE, Perrier ND, Graham PH, Hyde SM, Nieves-Munoz F, Cabanillas ME, Waguespack SG, Cote GJ, Gagel RF, Grubbs EG. Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness. J Clin Endocrinol Metab. 2017 Aug.102(8):2807-2813. Pubmedid: 28609830. Pmcid: PMC5546858.
• Voss RK, Woods TN, Cromwell KD, Nelson KC, Cormier JN. Improving outcomes in patients with melanoma: strategies to ensure an early diagnosis. Patient Relat Outcome Meas. 2015 Nov.6:229-242. Pubmedid: 26609248. Pmcid: PMC4644158.
• Voss RK, Cromwell KD, Chiang YJ, Armer JM, Ross MI, Lee JE, Gershenwald JE, Stewart BR, Shaitelman SF, Cormier JN. The long-term risk of upper-extremity lymphedema is two-fold higher in breast cancer patients than in melanoma patients. J Surg Oncol. 2015 Dec.112(8):834-840. Pubmedid: 26477877. Pmcid: PMC4715673.